Defunct Company
Total Trials
4
As Lead Sponsor
2
As Collaborator
Total Enrollment
301
NCT00080457
Safety and Efficacy Study of Sitaxentan Sodium (Thelin™) in Patients With Pulmonary Arterial Hypertension
Phase: Phase 3
Role: Lead Sponsor
Start: May 31, 2003
Completion: Jan 31, 2005
NCT00039858
Evaluation of Argatroban Injection in Pediatric Patients Requiring Anticoagulant Alternatives to Heparin
Phase: Phase 4
Start: Sep 30, 2003
Completion: Mar 31, 2006
NCT00817037
Sitaxsentan in Proteinuric Chronic Kidney Disease
Phase: Phase 2
Role: Collaborator
Start: Jul 14, 2007
Completion: Jul 7, 2009
NCT01100736
Role of Endothelin-A (ETA) and Endothelin-B (ETB) Receptors in the Vasodilatory Response to Endothelin-3 (ET-3)
Phase: Early Phase 1
Start: Jan 31, 2009
Completion: Jan 31, 2010